Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.10
-0.11 (-2.11%)
At close: Mar 30, 2026, 4:00 PM EDT
5.12
+0.02 (0.39%)
After-hours: Mar 30, 2026, 7:24 PM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
918958200199635320
Market Cap Growth
168.90%379.19%0.34%-68.65%98.76%-
Enterprise Value
719.37757.5279.4147.24450.53178.17
Last Close Price
5.105.371.451.565.033.17
PE Ratio
--12.79-4.03-4.73-13.59-2.42
PS Ratio
--235.10---
PB Ratio
4.624.871.601.343.502.28
P/TBV Ratio
4.084.301.591.332.911.42
P/FCF Ratio
--19.48-4.45-4.90-18.50-15.05
P/OCF Ratio
--19.49-4.46-4.90-18.62-16.25
EV/Sales Ratio
--93.43---
EV/EBITDA Ratio
--10.44-1.42-0.95-11.02-2.19
EV/EBIT Ratio
--10.40-1.40-0.94-10.82-2.18
EV/FCF Ratio
--15.41-1.77-1.16-13.12-8.39
Debt / Equity Ratio
0.040.040.050.000.010.02
Debt / EBITDA Ratio
-0.13-0.13-0.12-0.04-0.07-0.05
Debt / FCF Ratio
-0.20-0.20-0.15-0.04-0.08-0.19
Net Debt / Equity Ratio
-1.01-1.01-0.96-1.01-1.01-1.00
Net Debt / EBITDA Ratio
2.742.742.143.044.491.73
Net Debt / FCF Ratio
4.054.052.683.715.356.62
Asset Turnover
-00.01000
Quick Ratio
14.9614.9614.2819.5411.5413.59
Current Ratio
15.0215.0214.9619.7312.0513.84
Return on Equity (ROE)
-41.29%-41.29%-36.07%-25.74%-24.38%-91.30%
Return on Assets (ROA)
-40.47%-40.47%-38.10%-28.25%-23.57%-79.63%
Return on Invested Capital (ROIC)
-5095.42%-5095.42%-3832.49%2383.48%3421.36%-9077.83%
Return on Capital Employed (ROCE)
-43.21%-43.21%-40.36%-30.29%-25.51%-88.55%
Earnings Yield
-7.24%-7.82%-24.83%-21.15%-7.36%-41.32%
FCF Yield
-5.35%-5.13%-22.47%-20.41%-5.40%-6.64%
Buyback Yield / Dilution
-14.78%-14.78%-8.15%-20.76%-67.31%-104.28%
Total Shareholder Return
-14.78%-14.78%-8.15%-20.76%-67.31%-104.28%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q